Sayana-Uniject Volumetric Delivery
NCT01298479 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25
Last updated 2018-12-07
Summary
The purpose of this study is to determine the volumetric delivery of the Uniject.
Conditions
- Volume Delivery
Interventions
- OTHER
-
Uniject
single use container
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Pfizer CT.gov Call Center · Pfizer
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2010-05-31
- Primary Completion
- 2010-06-30
- Completion
- 2010-06-30
Countries
- Belgium
Study Locations
More Related Trials
-
Safety During Use of Paediatric Triple Chamber Bag Formulas
NCT01304394 ·Status: COMPLETED ·Phase: PHASE3
-
Phase 3 Study of Intranasal Carbetocin (LV-101) in Patients With Prader-Willi Syndrome
NCT03649477 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy, Safety, and Pharmacokinetics (PK) Study of Ulimorelin in Patients With Enteral Feeding Intolerance (EFI): The PROMOTE Trial
NCT02784392 ·Status: COMPLETED ·Phase: PHASE2
-
Phase I Pilot Study of Liver-Directed Gene Therapy for Partial Ornithine Transcarbamylase Deficiency
NCT00004386 ·Status: TERMINATED ·Phase: PHASE1
-
Low Dose of Sugammadex vs Neostigmine and Glycopyrrolate for the Reversal of Rocuronium
NCT05718934 ·Status: COMPLETED ·Phase: PHASE4
-
The Surrogate Project (Surrogate Storytelling)
NCT01902784 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
"Low Dose Sugammadex Combined With Neostigmine and Glycopyrrolate Versus Full Dose Sugammadex for Reversal of Rocuronium-induced Neuromuscular Blockade: a Cost Saving Strategy"
NCT02375217 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Methylnaltrexone (Relistor) on Digestion and Tolerance to Tube Feeding in Patients Treated With Opiates
NCT01360372 ·Status: WITHDRAWN ·Phase: PHASE3
-
Staccato Zaleplon Single Dose Pharmacokinetics
NCT00620620 ·Status: COMPLETED ·Phase: PHASE1
-
Nocturnal Cyclic Enteral Nutrition Infusion Versus Continuous Infusion of Enteral Nutrition
NCT03727165 ·Status: WITHDRAWN ·Phase: NA
-
Nutritional Tolerance and Safety of a Tube Feeding Formula
NCT05848583 ·Status: TERMINATED ·Phase: NA
-
Injection in the Treatment of Lateral Epicondylitis. Randomized Controlled Trial
NCT04875338 ·Status: COMPLETED ·Phase: PHASE3
-
Acute Effects of Propylene Glycol/Glycerol Intake on Blood Parameters
NCT03404011 ·Status: COMPLETED ·Phase: NA
-
Phase II RCT to Assess Efficacy of Intravenous Administration of Oxytocin in Patients Affected by COVID-19
NCT04386447 ·Status: WITHDRAWN ·Phase: PHASE2
-
Sugammadex Versus Neostigmine for Reversal of Neuromuscular Blockade at the End of Kidney Transplantation Surgery
NCT03923556 ·Status: COMPLETED ·Phase: PHASE4
-
Comparative Phase 3 Trial to Assess the Safety and Efficacy of Triple-chamber Parenteral Nutrition Formulation
NCT01579097 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate Solesta for Treatment of Fecal Incontinence
NCT01110681 ·Status: COMPLETED ·Phase: NA
-
Acceptability and Tolerance Study of a High Energy Tube Feed with Food Derived Ingredients
NCT06034951 ·Status: COMPLETED ·Phase: NA
-
Study of Sugammadex Versus Usual Care on Incidence of Residual Blockade at Post Anesthesia Care Unit Admission (P07981)
NCT01479764 ·Status: COMPLETED ·Phase: PHASE3
-
Self-injection and Self-management
NCT02417493 ·Status: COMPLETED ·Phase: NA
-
A Study Comparing Organic Phosphate (Sodium Glycerophosphate Injection) to Numeta G16%E
NCT06842134 ·Status: COMPLETED ·Phase: PHASE1
-
Using Lignocaine Spray and Gel to Reduce the Pain Associated With Nasogastric Tube Insertion in Children
NCT01075789 ·Status: TERMINATED ·Phase: NA
-
Dose Escalating Study of Rotigotine in Pediatric Subjects With Restless Legs Syndrome
NCT01495793 ·Status: COMPLETED ·Phase: PHASE2
-
Sugammadex Dose Finding Under Two Years Old
NCT06575036 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Lanreotide Autogel Treatment of Patients With Congenital Hyperinsulinism of Infancy
NCT01070758 ·Status: COMPLETED ·Phase: PHASE4